Cost-related prescription nonadherence in the united states and Canada: A system-level comparison using the 2007 international health policy survey in seven countries

Clinical Therapeutics

Volumn 31, Issue 1, 2009, Pages 213-219

  Kennedy, Jae ^a   Morgan, Steve ^b  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

adherence; cost; drug; International Health Policy Survey in Seven Countries; prescription

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; CHRONIC DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FINANCIAL MANAGEMENT; HEALTH CARE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH INSURANCE; HOUSEHOLD; HUMAN; INCOME; MALE; MEDICAID; MEDICARE; PRESCRIPTION; RISK; SEX; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CANADA; DRUG COSTS; FEMALE; HEALTH SURVEYS; HUMANS; INSURANCE, PHARMACEUTICAL SERVICES; MALE; MEDICALLY UNINSURED; MEDICATION ADHERENCE; MIDDLE AGED; PRESCRIPTION DRUGS; UNITED STATES; YOUNG ADULT;

EID: 60349131579     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2009.01.006     Document Type: Article

References (46)

1. Forrest S., Goetghebeur M.M., and Hay J. Medicare coverage and reimbursement of outpatient prescription drugs in the US: History, recent changes and outlook for the future. Appl Health Econ Health Policy 4 (2005) 9-14
2. Wysowski D.K., Governale L.A., and Swann J. Trends in outpatient prescription drug use and related costs in the US: 1998-2003. Pharmaco Economics 24 (2006) 233-236
3. Morgan S. Drug spending in Canada: Recent trends and causes. Med Care 42 (2004) 635-642
4. Catlin A., Cowan C., Hartman M., Heffler S., and National Health Expenditure AccountsTeam. National health spending in 2006: A year of change for prescription drugs. [published correction appears in]. Health Aff (Millwood) 27 (2008) 593
5. Catlin A., Cowan C., Hartman M., Heffler S., and National Health Expenditure AccountsTeam. National health spending in 2006: A year of change for prescription drugs. Health Aff (Millwood) 27 (2008) 14-29
6. Zeber J.E., Grazier K.L., Valenstein M., et al. Effect of a medication copayment increase in veterans with schizophrenia. Am J Manag Care 13 (2007) 335-346
7. Sherman F.T. Medication nonadherence: A national epidemic among America's seniors. Geriatrics 62 (2007) 5-6
8. Park J., and Campese V. Clinical characteristics of resistant hypertension: The importance of compliance and the role of diagnostic evaluation in delineating pathogenesis. J Clin Hypertens (Greenwich) 9 Suppl 1 (2007) 7-12
9. Byerly M.J., Nakonezny P.A., and Lescouflair E. Antipsychotic medication adherence in schizophrenia. Psychiatr Clin North Am 30 (2007) 437-452
10. Briesacher B.A., Gurwitz J.H., and Soumerai S.B. Patients at-risk for cost-related medication nonadherence: A review of the literature. J Gen Intern Med 22 (2007) 864-871
11. Soumerai S.B., Pierre-Jacques M., Zhang F., et al. Cost-related medication nonadherence among elderly and disabled Medicare beneficiaries: A national survey 1 year before the Medicare drug benefit. Arch Intern Med 166 (2006) 1829-1835
12. Haynes R.B., Ackloo E., Sahota N., et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev (2008) CD000011
13. The Henry J. Kaiser Family Foundation. Medicare Fact Sheet: The Medicare Prescription Drug Benefit (2007), Kaiser Family Foundation, Menlo Park, Calif
14. The Henry J. Kaiser Family Foundation. Kaiser Commission on Medicaid and the Uninsured. The Uninsured: A primer: Key facts about Americans without health insurance (2007), Kaiser Family Foundation, Menlo Park, Calif
15. The Kaiser Family Foundation and Health Research and Education Trust. Employer Health Benefits: 2006 Summary of Findings (2006), Kaiser Family Foundation, Menlo Park, Calif
16. The Kaiser Family Foundation. Prescription drug trends: A chartbook update (2001), Kaiser Family Foundation, Menlo Park, Calif
17. Schoen C., Collins S.R., Kriss J.L., and Doty M.M. How many are undennsured? Trends among U.S. adults, 2003 and 2007. Health Aff (Millwood) 27 (2008) w298-w309
18. Kapur V., and Basu K. Drug coverage in Canada: Who is at risk?. Health Policy. 71 (2005) 181-193
19. Morgan S.G. Prescription drug expenditures and population demographics. Health Serv Res 41 (2006) 411-428
20. Demers V., Melo M., Jackevicius C., et al. Comparison of provincial prescription drug plans and the impact on patients' annual drug expenditures. CMAJ 178 (2008) 405-409
21. Anis A.H., Guh D., and Wang X. A dog's breakfast: Prescription drug coverage varies widely across Canada. Med Care 39 (2001) 315-326
22. Dewa C.S., Hoch J.S., and Steele L. Prescription drug benefits and Canada's uninsured. Int J Law Psychiatry 28 (2005) 496-513
23. Gray J. Experience with providing drugs for seniors in Canada. Am J Genatr Cardiol. 14 (2005) 313-316
24. Pomey M.P., Forest P.G., Palley H.A., and Martin E. Public/private partnerships for prescription drug coverage: Policy formulation and outcomes in Quebec's universal drug insurance program, with comparisons to the Medicare prescription drug program in the United States. Milbank Q 85 (2007) 469-498
25. Tamblyn R. The impact of pharmacotherapy policy: A case study. Can J Clin Pharmacol. 8 Suppl A (2001) 39A-44A
26. Hanley G.E., Morgan S., Hurley J., and van Doorslaer E. Distributional consequences of the transition from age-based to income-based prescription drug coverage in British Columbia, Canada. Health Econ 17 (2008) 13791392
27. Li X., Guh D., Lacaille D., et al. The impact of cost sharing of prescription drug expenditures on health care utilization by the elderly: Own-and cross-price elasticities. Health Policy 82 (2007) 340-347
28. Kennedy J., and Erb C. Prescription noncompliance due to cost among adults with disabilities in the United States. Am J Public Health 92 (2002) 1120-1124
29. Kennedy J., and Morgan S. A cross-national study of prescription non-adherence due to cost: Data from the Joint Canada-United States Surveyor Health. Clin Ther 28 (2006) 1217-1224
30. Morgan S.G., Barer M.L., and Agnew J.D. Whither seniors' pharmacare: Lessons from (and for) Canada. Health Aff (Millwood) 22 (2003) 49-59
31. Coombes M.E., Morgan S.G., Barer M.L., and Paghccia N. Who's the fairest of them all? Which provincial pharmacare model would best protect Canadians against catastrophic drug costs. Healthc Q 7 Suppl (2004) 13-19
32. Kennedy J., Coyne J., and Sclar D. Drug affordabihty and prescription noncompliance in the United States: 1997-2002. Clin Ther 26 (2004) 607-614
33. The Commonwealth Fund (CMWF). International Health Policy Survey in Seven Countries (2007). http://www.commonwealthfund.org/surveys/surveys_show.htm?doc_id=568326 Accessed October 31, 2008.
34. Anderson R., and Newman J.F. Societal and individual determinants of medical care utilization in the US. MilbankQ 51 (1973) 95-124
35. Harris Interactive I. Methodology report: International Health Perspectives 2007 (2007), Harris Interactive, New York, NY
36. Statistics Canada. Canadian population data, CANSIM II, V466674, Ottawa, Ontario, Canada (2008)
37. National Center for Health Statistics. Summary Health Statistics for the U.S. Population (2008), National Health Interview Survey, Bethesda, Md No. 236
38. SAS Institute Inc. SAS/STATVersion 9.1 (2008), SAS Institute lne, Cary, NC
39. Research Triangle Institute. Software for the Statistical Analysis of Correlated Data (SUDAAN). 9.0 ed (2004), Research Triangle Institute, Research Triangle Park, NC
40. Schoen C., Osborn R., Doty M.M., et al. Toward higher-performance health systems: Adults' health care experiences in seven countries, 2007. Health Aff (Millwood) 26 (2007) w717-w734
41. Moon M. How beneficiaries fare under the new Medicare drug bill. Issue Brief (Commonw Fund) (2004) 1-16
42. Kennedy J., and Morgan S. Health care access in three nations: Canada, insured America, and uninsured America. Int J Health Serv 36 (2006) 697-717
43. Morgan S. Sources of variation in provincial drug spending. CMAJ 170 (2004) 329-330
44. Poisal J.A. Reporting of drug expenditures in the MCBS. Health Care Financ Rev 25 (2003) 23-36
45. Urquhart J. Role of patient compliance in clinical pharmacokinetics. A review of recent research. Clin Pharmacokmet 27 (1994) 202-215
46. Evans C., and Crawford B. Patient self-reports in pharmacoeconomic studies. Their use and impact on study validity. Pharmaco Economics 15 (1999) 241-256